Photodynamic Therapy for Urological Malignancies: Past to Current Approaches
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
PURPOSE: Modern PDT for urological tumors is a potentially selective approach in which in situ photosensitization by a nontoxic drug, locally activated by light, generates cytotoxic reactive oxygen species, causing cell death. While urological clinical experience with PDT is largely limited to treatment for superficial bladder cancer, the advent of novel photosensitizers and technologies for treatment planning, light delivery and dosimetry, PDT for prostate and other urological cancers appears increasingly realistic. MATERIALS AND METHODS: We reviewed the current literature on PDT for urological tumors, in addition to recent emerging data from our laboratory and elsewhere. RESULTS: Remarkable progress has been made in the field of photochemistry and photobiology. Together with improved optical delivery and imaging systems PDT holds promise as an alternative, minimally invasive and potentially curative treatment for localized solid tumors as well as for palliative treatment for isolated, clinically problematic metastases. CONCLUSIONS: Current experience with photodynamic therapy using contemporary photosensitizing agents and light sources is mainly restricted to in vivo experimental models and early phase clinical trails. However, ongoing preclinical work and clinical trials indicate that safer and effective PDT treatments in uro-oncology are imminent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., & Peng, Q. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.889 · Cited by 4,716
Cited by
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
“immunotherapies such as BCG or chemotherapies such as mitomycin C with PDT showed that these therapies may significantly enhance the PDT responsiveness of bladder tumors.(238,239) Despite these promising results, PDT for bladder cancer remains largely investigational with limited use.”
BackgroundSelf-citationThe role of porphyrin chemistry in tumor imaging and photodynamic therapy
Ethirajan, M., Chen, Y., Joshi, P., & Pandey, R. K. (2011) · Chem. Soc. Rev. · doi:10.1039/b915149b · Cited by 2,034
Oncologic photodynamic therapy photosensitizers: A clinical review
Allison, R. R., & Sibata, C. H. (2010) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2010.02.001 · Cited by 836
Photodynamic therapy for prostate cancer—a review of current status and future promise
Moore, C. M., Pendse, D., & Emberton, M. (2009) · Nature Clinical Practice Urology · doi:10.1038/ncpuro1274 · Cited by 331
Senge, M. O., & Brandt, J. C. (2011) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2011.00986.x · Cited by 313
Metadata
- Authors
- Pinthus, J. H., Bogaards, A., Weersink, R., Wilson, B. C., & Trachtenberg, J.
- Venue
- Journal of Urology
- Published
- 2006-04
- Volume
- 175
- Issue
- 4
- Pages
- 1201-1207
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2105162983
- Cited by
- 109
- References
- 1
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Photodynamic Therapy for Urological Malignancies: Past to Current Approaches. https://app.cochat.ai/papers/10.1016/s0022-5347(05)00701-9
- The paper
- Pinthus, J. H., Bogaards, A., Weersink, R., Wilson, B. C., & Trachtenberg, J. (2006). Photodynamic Therapy for Urological Malignancies: Past to Current Approaches. Journal of Urology. https://doi.org/10.1016/s0022-5347(05)00701-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.